News
Business
Marketing
Medical
Cronos Group partners with Geocann to leverage VESIsorb® absorption tech
June 27, 2022 By Haley Nagasaki
(Globe Newswire) Toronto—Cronos Group Inc. launches the first of what they expect will be a range of products in partnership with Geocann, using the advanced absorption technology VESIsorb® delivery system. The characteristics of VESIsorb® include superior pharmacokinetic performance, faster absorption, and higher plasma concentration, thereby securing industry standard status.
Cannabinoids and terpenes are categorized along with other difficult-to-absorb ingredients, creating a demand in the cannabis industry for innovative technologies that increase bioavailability. At this time, Geocann is the exclusive supplier of the VESIsorb® absorption technology.
“We are committed to bringing breakthrough innovations to the market, providing consumers with differentiated and high-quality products. Working with Geocann’s technology enables us to expand our product offering to bring consumers a fast-acting cannabinoid product with a quicker onset than previously available, along with improved efficacy, helping enhance and differentiate effect and experience.” —Mike Gorenstein, Chairman, President and Chief Executive Officer, Cronos
Print this page
